A Long-Term Safety and Efficacy Study of Lorecivivint in Subjects With Osteoarthritis of the Knee

NCT04520607 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

276

Enrollment

INDUSTRY

Sponsor class

Stopped Study OA-07 was designed to be conducted until the Sponsor closed it. Study OA-07 was administratively closed at Visit 6E (Week 100), with no safety concerns, one year into the open-label study as described in the protocol.

Conditions

Osteoarthritis, Knee

Interventions

DRUG: Placebo
DRUG: Lorecivivint

Sponsor

Biosplice Therapeutics, Inc.